Shares of Kane Biotech Inc. (CVE:KNE – Get Free Report) reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as C$0.03 and last traded at C$0.03, with a volume of 4000 shares. The stock had previously closed at C$0.04.
Kane Biotech Stock Performance
The stock has a 50-day simple moving average of C$0.03 and a 200-day simple moving average of C$0.04. The company has a market capitalization of C$5.02 million, a price-to-earnings ratio of -0.38 and a beta of 0.29. The company has a current ratio of 0.80, a quick ratio of 0.39 and a debt-to-equity ratio of -331.42.
About Kane Biotech
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.
Featured Articles
- Five stocks we like better than Kane Biotech
- How to Invest in Small Cap Stocks
- Higher Beef Prices Are Here: Best Steakhouse Stocks for 2026
- How to Buy Gold Stock and Invest in Gold
- AI Runs on Power—And Constellation Energy Controls the Switch
- How to Read Stock Charts for Beginners
- 3 Insider Moves You Shouldn’t Ignore Heading Into 2026
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
